China to launch clinical trial of new lupus drug

The new drug SM934 is a water-soluble artemisinin derivative developed by researchers with the Shanghai Institute of Materia Medica under the CAS. It has been patent protected. Approved by the ...

Read the original article: shanghai china - BingNews